VPHM is trading close to the $10.03 lower bound of the collar, which explains why LEVP (2.43) is far below the nominal buyout price of 2.75 plus future considerations.
Let’s talk biotech! “The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”